EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

IGH/IGK gene rearrangement in the diagnosis of B-cell non-Hodgkin lymphoma: experience from three centers

Ke Yang, Zhizhong Wang, Beibei Xin, Yunhang Li, Jiuzhou Zhao, Rui Sun, Weizhen Wang, Dongxu Chen, Chengzhi Zhao, Yongjun Guo, Jie Ma, Bing Wei

Annals of Hematology · 2025

DOI: 10.1007/s00277-025-06452-5 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Annals of Hematology, 2025. Verfasst von Ke Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular pathology, the Affiliated Cancer Hospital of Zhengzhou University & Henan Caner Hospital, Zhengzhou, 450008, China. Hauptthemen laut MEDLINE: Lymphoma, B-Cell, Immunoglobulin Heavy Chains, Immunoglobulin kappa-Chains, Gene Rearrangement. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Major Science and Technology Project of Henan Province, Technological and scientific projects in Henan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

B-cell non-Hodgkin lymphomas (B-NHL) are a heterogeneous group of malignancies that pose significant diagnostic challenges due to their clinical and molecular diversity. Traditional detection methods (e.g., morphology and immunohistochemistry) could confirm most cases, but 10% remain difficult to diagnose. Comparatively, immunoglobulin clonality assessment has great potential to support the diagnosis of lymphocytic malignancies. This study retrospectively analyzed 996 patients with suspected B-NHL and reactive lymphoid hyperplasia (RLH) from three centers. Immunoglobulin heavy/light chain (IGH/IGK) gene rearrangements were detected using capillary electrophoresis, and results were compared with final diagnoses based on clinical follow-up. Among 978 cases with definitive diagnoses, 97.1% (369/380) of B-NHL patients showed IGH/IGK gene rearrangements, while 99.7% (596/598) of non-B-NHL patients were negative. The combined evaluation of morphology and IGH/IGK rearrangement improved the sensitivity from 70.8 to 98.2% and the accuracy from 81.7 to 92.1% over morphology alone. The combined assessment of morphology, immunohistochemistry and IGH/IGK rearrangement improved the sensitivity from 71.6 to 98.2% and the accuracy from 83.2 to 93.4% compared to the combined assessment of morphology and immunohistochemistry. Additionally, IGH rearrangements were more frequent than IGK rearrangements in B-NHL patients, with significant differences in rearrangement patterns among B-NHL subtypes. The IGH rearrangement was mainly found in small lymphocytic lymphomas, diffuse large B-cell lymphoma and follicular lymphoma; the IGK rearrangements were mainly found in B-cell lymphoblastic lymphomas and marginal zone lymphoma; the IGH and IGK rearrangements were mainly found in mantle cell lymphoma and multiple myeloma. In conclusion, IGH/IGK rearrangement analysis showed high consistency with final diagnoses, supporting its integration into routine clinical diagnostics to improve the accuracy of B-NHL diagnosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphoma, B-CellImmunoglobulin Heavy ChainsImmunoglobulin kappa-ChainsGene RearrangementGene Rearrangement, B-Lymphocyte, Heavy ChainHumansFemaleMaleRetrospective StudiesMiddle AgedAgedAdultAged, 80 and overYoung AdultAdolescentImmunoglobulins

Stichwörter der Autor:innen

Auxiliary diagnosisB-cell non-Hodgkin lymphomaIGH gene rearrangementIGK gene rearrangement

Substanzen

Immunoglobulin Heavy ChainsIgKImmunoglobulin kappa-ChainsImmunoglobulins

Autor:innen und Institutionen

  • Department of Molecular pathology, the Affiliated Cancer Hospital of Zhengzhou University & Henan Caner Hospital, Zhengzhou, 450008, China.
  • Shanghai Rightongene Biotechnology Co., Ltd., Shanghai, 201403, China.
  • Department of Molecular pathology, the Affiliated Cancer Hospital of Zhengzhou University & Henan Caner Hospital, Zhengzhou, 450008, China. yongjunguo@hotmail.com.
  • Department of Molecular pathology, the Affiliated Cancer Hospital of Zhengzhou University & Henan Caner Hospital, Zhengzhou, 450008, China. majie@medmail.com.cn.
  • Department of Molecular pathology, the Affiliated Cancer Hospital of Zhengzhou University & Henan Caner Hospital, Zhengzhou, 450008, China. zlyyweibing0629@zzu.edu.cn.

Förderung

  • Major Science and Technology Project of Henan Province
  • Technological and scientific projects in Henan Province

Zitieren

APA

Yang, K., Wang, Z., Xin, B., Li, Y., Zhao, J., Sun, R., Wang, W., Chen, D., Zhao, C., Guo, Y., Ma, J., & Wei, B. (2025). IGH/IGK gene rearrangement in the diagnosis of B-cell non-Hodgkin lymphoma: experience from three centers. Annals of Hematology. https://doi.org/10.1007/s00277-025-06452-5

Vancouver

Yang K, Wang Z, Xin B, Li Y, Zhao J, Sun R, et al. IGH/IGK gene rearrangement in the diagnosis of B-cell non-Hodgkin lymphoma: experience from three centers. Annals of Hematology. 2025. doi:10.1007/s00277-025-06452-5

BibTeX
@article{Yang2025,
  author = {Yang, Ke and Wang, Zhizhong and Xin, Beibei and Li, Yunhang and Zhao, Jiuzhou and Sun, Rui and Wang, Weizhen and Chen, Dongxu and Zhao, Chengzhi and Guo, Yongjun and Ma, Jie and Wei, Bing},
  title = {IGH/IGK gene rearrangement in the diagnosis of B-cell non-Hodgkin lymphoma: experience from three centers},
  journal = {Annals of Hematology},
  year = {2025},
  doi = {10.1007/s00277-025-06452-5}
}
Kostenlos starten →